Abstract
Wasabi nose, a term used to describe the nasopharyngeal discomfort experienced during cyclophosphamide infusions, is a rare phenomenon, previously described in case reports of adult oncology patients typically receiving high-dose chemotherapy regimens. The underlying mechanism by which this phenomenon occurs is unknown. We report four cases of children with rheumatic diseases afflicted by profound nasopharyngeal discomfort secondary to low-dose cyclophosphamide infusions. We additionally review the literature regarding potential medical management of these complications and describe our experience using these interventions.
Similar content being viewed by others
References
Lo KAA, Gingerich K, Taylor S (2002) Cyclophosphamide-induced nasopharyngeal discomfort (wasabi nose): a report of two cases. J Oncol Pharm Pract 8:131–134
Schwinghammer TL, Wiggins LE, Burgunder MR, Michell TE, Bailey WL (1994) Adverse reactions related to i.v. infusion of high-dose cyclophosphamide in bone marrow transplant patients. Am J Hosp Pharm 51(19):2419–2421
Lipton JH (1995) Therapy of cyclophosphamide-induced nasal congestion. Bone Marrow Transplant 16(4):634
Arena PJ (1972) Oropharyngeal sensation associated with rapid intravenous administration of cyclophosphamide (NSC-26271). Cancer Chemother Rep 56(6):779–780
Kosirog-Glowacki JL, Bressler LR (1994) Cyclophosphamide-induced facial discomfort. Ann Pharmacother 28(2):197–199
Silberstein PT, Vercellotti GM (1984) Facial burning from cyclophosphamide. Cancer Treat Rep 68(7–8):1057
Financial Support or Funding
None.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Janow, G.L., Ilowite, N.T. & Wahezi, D.M. Wasabi nose: an underreported complication of cyclophosphamide infusions. Clin Rheumatol 30, 1003–1005 (2011). https://doi.org/10.1007/s10067-011-1728-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1728-z